SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
USA Rare Earth, Inc. entered into a direct funding agreement with the U.S. Department of Commerce dated June 3, 2026, for the Round Top and Stillwater...
TransCode Therapeutics announced positive Phase 1a results for its lead candidate TTX-MC138, showing safety, tolerability, and disease stabilization i...
Rent the Runway reported Q1 2026 results with total revenue of $89.9 million, up 29.2% year-over-year, while add-on revenue surged 70.4% YoY. The comp...
RadNet announced plans to secure a $200 million incremental term loan to fund acquisitions, organic expansion, and health system partnerships. The fin...
BioLife Solutions released a June 2026 investor presentation outlining its industry-leading solutions for cell-based therapies. The presentation inclu...
Richtech Robotics completed acquisition of a 79,325 sq ft Las Vegas facility for $21.2M to support AI infrastructure and robotics operations across it...
1606 Corp executed a Third Amendment to its Purchase and Sale Agreement with Jefferson Enterprise Energy, LLC, extending the acquisition closing deadl...
Digi Power X secured a $35 million commitment to purchase NVIDIA's next-generation Vera Rubin GPU systems for deployment in Q1 2027 to expand its NeoC...
NewAmsterdam Pharma Company N.V. has adopted an Employee Stock Purchase Plan (ESPP) authorizing up to 1,150,000 shares for eligible employees under IR...
Dyne Therapeutics announced full enrollment in the registrational expansion cohort of its ACHIEVE trial for Z-basivarsen, with topline data expected i...
TG Therapeutics announced positive pharmacokinetic and pharmacodynamic results from a Phase 1 trial of subcutaneous BRIUMVI, demonstrating greater tha...
GlobalTech Corp issued a shareholder update emphasizing disciplined execution, transparent reporting, and responsible AI innovation rather than predic...
Destination XL Group's Board is renegotiating its merger of equals with FullBeauty Brands, citing challenging consumer environment and FullBeauty's de...
Destination XL Group reported Q1 FY2026 sales of $103.3 million with net loss of $5.9 million ($0.11 per diluted share), as comparable store sales dec...
Avalyn completed an upsized IPO raising $345 million gross proceeds and reported progress on three pulmonary fibrosis programs, with MIST Phase 2b enr...
Sprinklr delivered solid first-quarter results with 7% total revenue growth and 6% subscription revenue growth, achieving $70.4M in operating cash flo...
Ollie's reported 14% net sales growth and 19% EPS growth in Q1 FY2026, exceeding expectations with margin expansion and strong comparable store sales....
Wellington Management will acquire Hartford Funds from The Hartford in a definitive agreement, integrating the business into Wellington's U.S. Wealth ...
AECOM's Board of Directors declared a quarterly cash dividend of $0.31 per share as part of its ongoing dividend program. The dividend payment demonst...
Cabaletta announced encouraging Phase 1/2 clinical data for rese-cel across dermatomyositis, systemic sclerosis, and lupus, with 83% of dermatomyositi...